Despite systematic elucidation of the roles of TMX family genes in pan-cancer from various perspectives such as expression pattern, poor prognosis, tumor immune microenvironment, stemness score, immune subtype and drug sensitivity, there are still certain shortcomings in the current research. This evidence concerns the gene TMX1 and neoplasm.